Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD 20892-2182, USA.
S E
SE
Straus
D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D002185:Cannabidiol / Q000737:chemistry / Q000276:immunology* / Q000627:therapeutic use*; D002188:Cannabis / Q000737:chemistry* / Q000276:immunology / Q000627:therapeutic use*; D000529:Complementary Therapies / Q000639:trends; D007107:Immune System / Q000276:immunology* / Q000378:metabolism; D008024:Ligands; D051379:Mice; D008517:Phytotherapy; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism
D008024:Ligands; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D002185:Cannabidiol